Model‐Based Assessment of Alternative Study Designs in Pediatric Trials. Part II: Bayesian Approaches
نویسندگان
چکیده
This study presents a pharmacokinetic-pharmacodynamic based clinical trial simulation framework for evaluating the performance of a fixed-sample Bayesian design (BD) and two alternative Bayesian sequential designs (BSDs) (i.e., a non-hierarchical (NON-H) and a semi-hierarchical (SEMI-H) one). Prior information was elicited from adult trials and weighted based on the expected similarity of response to treatment between the pediatric and adult populations. Study designs were evaluated in terms of: type I and II errors, sample size per arm (SS), trial duration (TD), and estimate precision. No substantial differences were observed between NON-H and SEMI-H. BSDs require, on average, smaller SS and TD compared to the BD, which, on the other hand, guarantees higher estimate precision. When large differences between children and adults are expected, BSDs can return very large SS. Bayesian approaches appear to outperform their frequentist counterparts in the design of pediatric trials even when little weight is given to prior information from adults.
منابع مشابه
Model‐Based Assessment of Alternative Study Designs in Pediatric Trials. Part I: Frequentist Approaches
Alternative designs can increase the feasibility of pediatric trials when compared to classical parallel designs (PaD). In this work we present a model-based approach based on clinical trial simulations for the comparison of PaD with the alternative sequential, crossover, and randomized withdrawal (RWD) designs. Study designs were evaluated in terms of: type I and II errors, sample size per arm...
متن کاملBayesian two-stage designs for phase II clinical trials.
Many different statistical designs have been used in phase II clinical trials. The majority of these are based on frequentist statistical approaches. Bayesian methods provide a good alternative to frequentist approaches as they allow for the incorporation of relevant prior information and the presentation of the trial results in a manner which, some feel, is more intuitive and helpful. In this ...
متن کاملBayesian designs of phase II oncology trials to select maximum effective dose assuming monotonic dose-response relationship
BACKGROUND For many molecularly targeted agents, the probability of response may be assumed to either increase or increase and then plateau in the tested dose range. Therefore, identifying the maximum effective dose, defined as the lowest dose that achieves a pre-specified target response and beyond which improvement in the response is unlikely, becomes increasingly important. Recently, a class...
متن کاملFull title: A likelihood-based approach to early stopping in single arm phase II cancer clinical trials Short title: Likelihood-based early stopping design in single arm phase II studies
In single arm phase II trials (in cancer research in particular), Simon’s twostage design has become most commonly used due to its simplicity, its ability to allow early stopping for futility, and preservation of type I and type II errors. As an alternative, likelihood-based approaches which allow frequent looks at the data and are similar to the Bayesian adaptive designs, whereby there is not ...
متن کاملPrediction Based on Type-II Censored Coherent System Lifetime Data under a Proportional Reversed Hazard Rate Model
In this paper, we discuss the prediction problem based on censored coherent system lifetime data when the system structure is known and the component lifetime follows the proportional reversed hazard model. Different point and interval predictors based on classical and Bayesian approaches are derived. A numerical example is presented to illustrate the prediction methods used in this paper. Mont...
متن کامل